… , assumingly through the production of protective antibodies … in the development and
progression of atherosclerosis and … IgM and IgG antibodies are present within atherosclerotic …

… atherosclerosis will lead to the identification and validation of biomarkers for atherosclerosis
and CVD, enabling the development … anti-apoA-1 antibodies in patients with severe carotid …

… However, further studies are still needed to determine whether atherosclerotic plaques in
autoimmune disease have special features, or to analyze which autoantigens, autoantibodies, …

… TFH cells enter germinal centers and provide T cell help to B cells, enabling antibody isotype
… with atherosclerosis, IgG and IgM antibodies to oxLDL are detectable. Higher IgM antibody …

… antibodies increases risk for atherosclerosis in humans with SLE. A recent study suggests
… anti-oxLDL antibodies develop after of anti-lipoprotein lipase autoantibodies are detected …

… Atherosclerosis is characterized by accumulation of dead cells… another important feature of
atherosclerosis, most likely being a … to be a major factor in atherosclerosis development, since …

… antibodies in vivo was studied (as were other autoantibodies) in animal models of AS. The
apo-E knockout mice developed … -receptor-deficient mice developed AS plaques only when …

… may progress into fully developed atherosclerotic lesions, displaying … Atherosclerosis is one
of the most prevalent fatal diseases in … clearly indicates that atherosclerosis is a multifactorial …

… by antigenic modulation of the CD3 antibody/T-cell receptor … specific antibodies might inhibit
atherosclerosis development … –specific antibodies inhibits atherosclerosis development and …

… recognized by IgG antibodies in the sera of patients with atherosclerosis. The presence of
autoantibodies against these … We then compared serum antibody levels against recombinant …